Medicamen Biotech informs about closure of trading window

03 Oct 2023 Evaluate
In terms of the provisions of the Code of Conduct to Regulate, Monitor and Report trading by Designated Persons and their immediate relative (the Code), Medicamen Biotech has informed that the Trading Window for dealing in the securities of the Company was closed for all Directors/ Designated Persons /Connected Persons under the Code from October 01, 2023 and the same will remain closed till 48 hours after the declaration of Unaudited Financial Results for the quarter ending September 30, 2023, to the public. Accordingly, all Directors/ Designated Persons/ Connected Persons under the Code have been advised not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. The date of meeting of the Board of Directors of the Company to approve the audited financial results of the Company for the aforesaid period will be intimated separately in due course of time. 

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

381.90 -8.35 (-2.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×